false
0001140859
0001140859
2025-09-05
2025-09-05
0001140859
us-gaap:CommonStockMember
2025-09-05
2025-09-05
0001140859
COR:Sec2.875SeniorNotesDue2028Member
2025-09-05
2025-09-05
0001140859
COR:Sec3.625SeniorNotesDue2032Member
2025-09-05
2025-09-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): September 5, 2025
Cencora, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 1-16671
| Delaware |
|
23-3079390 |
| (State or other jurisdiction of |
|
(I.R.S. Employer |
| incorporation or organization) |
|
Identification No.) |
1 West First Avenue
Conshohocken, PA |
|
19428-1800 |
| (Address of principal executive offices) |
|
(Zip Code) |
(610) 727-7000
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report.)
Securities registered pursuant
to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of exchange on which registered |
| Common Stock |
COR |
New York Stock Exchange (NYSE) |
| 2.875% Senior Notes due 2028 |
COR28 |
New York Stock Exchange (NYSE) |
| 3.625% Senior Notes due 2032 |
COR32 |
New York Stock Exchange (NYSE) |
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 1.01 | Entry into a Material Definitive Agreement. |
Amendment of Term
Loan
On September 5, 2025, Cencora, Inc. (the “Company”)
entered into Amendment No. 2 (the “Term Credit Amendment”) to the Term Credit Agreement, dated as of November 26, 2024,
among the Company, the lenders party thereto and Bank of America, N.A., as administrative agent, as amended by Amendment No. 1, dated
as of June 4, 2025 (the “Term Credit Agreement”, as amended by the Term Credit Amendment, the “Amended Term Credit Agreement”),
pursuant to which the Company and certain subsidiaries previously obtained a senior unsecured term loan (the “Term Loan”).
The Term Credit Amendment amended the Term
Credit Agreement to change the maturity date from January 2, 2028 to October 1, 2027 and modify the interest rate at which the Term
Loan bears interest. The Term Loan bears interest at a rate equal to either an adjusted Term SOFR rate plus an applicable margin or an
alternate base rate plus an applicable margin, in each case based on the Company’s public debt ratings by Standard & Poor’s
Ratings Services, Moody’s Investors Service, Inc. and Fitch, Inc. Pursuant to the Amended Term Credit Agreement, such
applicable margins range from 62.5 basis points to 125.0 basis points over the adjusted Term SOFR rate and 0 basis points to 25.0 basis
points over the alternate base rate, in each case, as determined in accordance with the provisions of the Amended Term Credit Agreement.
The foregoing description of the Term Credit
Amendment does not purport to be complete and is qualified in its entirety by reference to the Term Credit Amendment, which is filed as
Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Amendment of Money
Market Facility
On September
5, 2025, the Company entered into Amendment No. 2 (the “Money Market Facility Amendment”) to the Uncommitted Money Market
Line Credit Agreement, dated as of June 10, 2022, between the Company and Société Générale, acting through
its New York Branch, as amended by Amendment No. 1, dated as of February 3, 2025 (the “Money Market Facility Agreement”),
pursuant to which the Company has the ability to request short-term, unsecured revolving credit loans from time to time (the “Money
Market Facility”).
The Money
Market Facility Amendment amended the Money Market Facility Agreement to, among other things, permit borrowings in a principal amount
of up to (i) $500 million on or after April 1 and before December 1 of any year and (ii) $750 million on or after December 1 and before
March 31 of any year. The Money Market Facility may be decreased or terminated by the bank or the Company at any time without prior
notice.
The foregoing description of the Money Market
Facility Amendment does not purport to be complete and is qualified in its entirety by reference to the Money Market Facility Amendment,
which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated by reference herein.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No. |
|
Description |
| 10.1 |
|
Amendment No. 2 to Term Credit Agreement, dated as of September 5, 2025, among the Company, the lenders party thereto, and Bank of America, N.A., as administrative agent. |
| 10.2 |
|
Amendment No. 2 to Uncommitted Money Market Line Credit Agreement, dated as of September 5, 2025, between the Company and Société Générale, acting through its New York Branch, as lender. |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Cencora, Inc. |
| |
|
|
| September 9,
2025 |
By: |
/s/ James F. Cleary |
| |
|
Name: James F. Cleary |
| |
|
Title: Executive Vice President and Chief Financial Officer |